Investors can still find some compelling valuations among large-cap drug companies even as major stock indices hit new highs.
Who stands to gain -- and who doesn't -- from the president's new proposal?
Stocks move higher, setting up the Dow and S&P to recover Monday's losses.
There's mixed interest in biotech, biopharmaceutical and emerging pharma companies.
These defensive plays yield up to 8%. And best of all, it's not too late to buy.
eBay is initiated with an 'outperform,' and BroadSoft is downgraded at 2 firms.
The month also features a big gathering of biotech CEOs in New York and a cancer research meeting in Florida.
VIDEO ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
Investors know what's working and what's not. These stocks could power higher through the end of the year.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
Six weeks later, most Americans have forgotten about the 2014 tax season -- except those who didn't file by the April 15 deadline.
MUST-SEE ON MSN
- Video: Easy DIY smoked meats at home
A charcuterie master shares his process for cold-smoking meat at home.
- Jetpacks about to go mainstream
- Weird things covered by home insurance
- Bing: 70 percent of adults report 'digital eye strain'